CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $121,100,000 | +9116.1% | 3,000 | -91.7% | 1.26% | +326.7% |
| Q1 2022 | $1,314,000 | 0.0% | 36,100 | 0.0% | 0.30% | +1.0% |
| Q4 2021 | $1,314,000 | -81.6% | 36,100 | -61.7% | 0.29% | -83.0% |
| Q3 2021 | $7,131,000 | +76.4% | 94,300 | +62.3% | 1.72% | +61.2% |
| Q2 2021 | $4,043,000 | -72.6% | 58,100 | -79.9% | 1.07% | -72.7% |
| Q1 2021 | $14,779,000 | -6.4% | 288,600 | +12.9% | 3.91% | -9.3% |
| Q4 2020 | $15,783,000 | +1121.6% | 255,600 | +983.1% | 4.31% | +933.8% |
| Q3 2020 | $1,292,000 | -87.7% | 23,600 | -87.7% | 0.42% | -88.0% |
| Q2 2020 | $10,465,000 | +37.2% | 191,600 | +0.8% | 3.48% | +0.0% |
| Q1 2020 | $7,629,000 | – | 190,000 | – | 3.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |